Skip to main content
U.S. FDA clears version 2.0 of Abbott's low-cost glucose monitor - Reuters India 16-Jun-2020
U.S. FDA clears version 2.0 of Abbott's low-cost glucose monitor - Reuters India
The U.S. Food and Drug Administration on Monday cleared a new version of Abbott Laboratories' continuous glucose monitoring device, helping the company build upon the success of its fastest-growing diabetes product.
More...